http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006003220-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38d829c310d34799cbae128ec69e15e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966480af70de9ec89a21b5035d89da34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e19ed5092514d4f22acfa3bc98b8b572
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-82
filingDate 2005-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf07bcb2a490164dd02c859875b759ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abb76da23875d7e40364623e641e83ad
publicationDate 2006-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006003220-A1
titleOfInvention Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles
abstract The invention relates to a method of preparing 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles having formula (I), wherein the asterisk (*) represents an asymmetrical carbon and R1 is alkyl C1-C6, the enantiomers or mixtures thereof, the pharmaceutically-acceptable solvates, hydrates or salts of same. The inventive method comprises the following steps consisting in: (a) reacting a compound (II) with a secondary amine, optionally in the presence of an acid and a solvent 1, in order to form an enamine; (b) optionally removing the acid and solvent 1 and, subsequently, reacting the enamine with sulphur in the presence of a solvent 2; and (c) reacting the previously obtained compound with cyanamide in order to obtain compound (I). Compounds having formula (I) include pramipexol which is a compound with dopamine D2 agonist activity that can be used for the treatment of Parkinson's disease and schizophrenia.
priorityDate 2004-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5708187-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026850-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3839223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226454548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13006
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136283266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87195513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422576663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227318894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13670698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11819262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423763738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410778979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467610095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57986939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454482646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID466102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13731266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422266980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467610141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18598488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227318891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487428

Total number of triples: 80.